Ibudon (Ibuprofen 400 mg Soft Capsule)

What Is Ibudon and What Is It Used For?

Ibudon is a prescription soft capsule containing 400 mg of ibuprofen, a non-steroidal anti-inflammatory drug (NSAID) that relieves pain, reduces inflammation, and lowers fever. It works by inhibiting cyclooxygenase (COX) enzymes, thereby reducing the production of prostaglandins responsible for pain and inflammation.

Ibuprofen, the active ingredient in Ibudon, belongs to the propionic acid class of NSAIDs and is one of the most widely used analgesic and anti-inflammatory drugs globally. It was first developed in the 1960s and has been included on the World Health Organization (WHO) Model List of Essential Medicines, reflecting its importance in global healthcare. The 400 mg soft capsule formulation of Ibudon is specifically designed to deliver the active substance in a pre-dissolved liquid form within a soft gelatin shell, which may facilitate faster dissolution in the gastrointestinal tract and potentially quicker onset of therapeutic effect.

Ibudon is commonly prescribed for a wide range of painful and inflammatory conditions. These include mild to moderate pain such as headache, migraine, dental pain, post-operative pain, and dysmenorrhoea (menstrual pain). It is also effective for musculoskeletal and joint pain including backache, sprains, strains, and the chronic pain associated with osteoarthritis and rheumatoid arthritis. Additionally, Ibudon can be used for the symptomatic relief of fever (pyrexia) in adults, including fever associated with common colds and influenza.

The mechanism of action of ibuprofen involves the non-selective inhibition of both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes. COX-2 inhibition reduces the synthesis of prostaglandins at sites of tissue injury and inflammation, which accounts for the analgesic and anti-inflammatory effects. However, COX-1 inhibition also affects the production of prostaglandins that protect the gastric mucosa and regulate platelet aggregation, which explains the gastrointestinal and bleeding-related side effects of ibuprofen.

Following oral administration of Ibudon soft capsules, ibuprofen is rapidly absorbed from the gastrointestinal tract. Peak plasma concentrations are typically reached within 1 to 2 hours. The drug is extensively bound to plasma proteins (approximately 99%) and is metabolised in the liver, primarily by the cytochrome P450 enzyme CYP2C9. The elimination half-life is approximately 2 hours, and the drug is excreted predominantly through the kidneys as inactive metabolites. The relatively short half-life means that ibuprofen does not accumulate significantly in the body with standard dosing regimens.

What Should You Know Before Taking Ibudon?

Before taking Ibudon, you should be aware of important contraindications, drug interactions, and special precautions. Ibudon is not suitable for everyone, and certain medical conditions, medications, and life stages require that you either avoid the drug entirely or use it with caution under medical supervision.

Contraindications

Ibudon should not be taken if you have any of the following conditions or circumstances:

• Known hypersensitivity to ibuprofen or any NSAID: This includes patients who have experienced asthma, urticaria (hives), angioedema, or rhinitis after taking aspirin or other NSAIDs. This is sometimes referred to as the "aspirin triad" or NSAID-exacerbated respiratory disease (NERD).
• Active peptic ulcer or gastrointestinal bleeding: NSAIDs inhibit protective prostaglandin production in the gastric mucosa, significantly increasing the risk of ulcer formation and bleeding. Patients with a history of recurrent peptic ulcer disease or GI haemorrhage (two or more distinct episodes) should also avoid ibuprofen.
• Severe heart failure (NYHA Class IV): NSAIDs can cause fluid retention and peripheral oedema, which can worsen cardiac function in patients with severe heart failure.
• Severe hepatic impairment: The liver is the primary site of ibuprofen metabolism, and severe liver dysfunction can lead to drug accumulation and toxicity.
• Severe renal impairment (GFR <30 mL/min): Ibuprofen reduces renal prostaglandin synthesis, which is essential for maintaining renal blood flow, particularly in patients with pre-existing kidney disease.
• Third trimester of pregnancy: NSAIDs can cause premature closure of the ductus arteriosus in the foetus, oligohydramnios, and delayed or prolonged labour.
• Active cerebrovascular or other active bleeding: Due to the antiplatelet effects of ibuprofen.

Warnings and Precautions

Even if none of the absolute contraindications apply, Ibudon should be used with caution in the following situations. The general principle for all NSAID use is to employ the lowest effective dose for the shortest duration necessary to control symptoms, as recommended by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).

Cardiovascular risk: All NSAIDs, including ibuprofen, are associated with a small but clinically significant increase in the risk of arterial thrombotic events such as myocardial infarction and stroke, particularly at high doses and with prolonged use. The PRECISION trial (2016) and subsequent meta-analyses have shown that ibuprofen at doses up to 1200 mg daily carries a lower cardiovascular risk compared to some other NSAIDs such as diclofenac. However, patients with established cardiovascular disease, uncontrolled hypertension, or significant cardiovascular risk factors should use Ibudon with particular caution.

Gastrointestinal risk: GI complications including bleeding, ulceration, and perforation can occur at any time during NSAID therapy, often without warning symptoms. Risk factors include advanced age (over 65 years), concurrent use of corticosteroids or anticoagulants, history of peptic ulcer disease, and alcohol consumption. Co-prescription of a proton pump inhibitor (PPI) should be considered for patients at increased GI risk who require ongoing NSAID therapy.

Renal effects: Long-term NSAID use can lead to renal papillary necrosis and other renal injury. Patients at greatest risk include those with impaired renal function, heart failure, liver dysfunction, those taking diuretics and ACE inhibitors, and the elderly. Adequate hydration should be maintained during Ibudon use.

Elderly patients: Older adults have a higher frequency of adverse reactions to NSAIDs, particularly gastrointestinal bleeding and perforation, which may be fatal. The lowest effective dose should be used, and renal function should be monitored.

Pregnancy and Breastfeeding

The use of Ibudon during pregnancy requires careful consideration depending on the trimester:

• First trimester: Some observational studies suggest a possible association between NSAID use in early pregnancy and an increased risk of miscarriage, although data are not conclusive. Use should be avoided unless clearly necessary.
• Second trimester: Ibudon may be used if the expected benefit justifies the potential risk to the foetus, but only at the lowest effective dose for the shortest possible duration.
• Third trimester: Ibudon is contraindicated. NSAIDs can cause premature closure of the foetal ductus arteriosus, foetal renal dysfunction leading to oligohydramnios, and inhibition of uterine contractions potentially delaying or prolonging labour.

Ibuprofen and its metabolites are excreted in breast milk in very small quantities. Because of the low concentrations and the short half-life of ibuprofen, short-term use at standard doses is generally considered compatible with breastfeeding by most international guidelines, including those from the American Academy of Pediatrics. However, prolonged use should be discussed with a healthcare provider.

How Does Ibudon Interact with Other Drugs?

Ibuprofen in Ibudon can interact with a wide range of medications, potentially increasing the risk of serious side effects or reducing the effectiveness of either drug. It is essential to inform your prescriber about all medications you are taking, including over-the-counter drugs and herbal supplements.

Drug interactions with ibuprofen are clinically significant and well-documented. The mechanisms of interaction typically involve competition for protein binding, effects on prostaglandin synthesis, or alterations in renal function. Below is a comprehensive overview of the most important drug interactions to be aware of when taking Ibudon.

Major Interactions

The most clinically significant interaction concerns low-dose aspirin used for cardiovascular protection. Pharmacological studies have demonstrated that concurrent ibuprofen can competitively block the irreversible COX-1 inhibition by aspirin in platelets, potentially negating the cardioprotective antiplatelet effect. The FDA has issued a specific advisory recommending that patients taking low-dose aspirin for cardiovascular protection should take the aspirin at least 30 minutes before or more than 8 hours after ibuprofen to avoid this interaction.

The interaction with anticoagulants such as warfarin, apixaban, rivaroxaban, and other direct oral anticoagulants (DOACs) is also of major clinical importance. Ibuprofen inhibits platelet aggregation and can cause gastrointestinal mucosal damage, both of which increase the bleeding risk when combined with anticoagulant therapy. International guidelines from bodies including the European Society of Cardiology recommend avoiding this combination whenever possible.

Co-administration with ACE inhibitors or angiotensin receptor blockers (ARBs), particularly in combination with diuretics (the so-called "triple whammy"), carries a significant risk of acute kidney injury. A large observational study published in the BMJ showed that this triple combination was associated with a 31% increased risk of acute kidney injury compared with dual therapy with any two of these agents.

Minor Interactions

Some less severe but nonetheless noteworthy interactions include those with antihypertensive medications in general. By inhibiting renal prostaglandin synthesis, ibuprofen can cause sodium and water retention, which may partially counteract the blood-pressure-lowering effects of antihypertensive drugs. This effect is generally modest but clinically relevant in some patients. Regular blood pressure monitoring is recommended when initiating NSAID therapy in patients on antihypertensive medication.

Ibuprofen may also modestly increase plasma concentrations of digoxin and phenytoin, although this interaction is rarely clinically significant at standard doses. Additionally, the absorption of quinolone antibiotics (such as ciprofloxacin) may theoretically be affected, though clinical evidence is limited. Patients should always inform their healthcare provider about all medications being taken, including herbal supplements such as ginkgo biloba and garlic supplements, which may further increase bleeding risk.

What Is the Correct Dosage of Ibudon?

The standard adult dose of Ibudon is one 400 mg soft capsule taken up to three times daily with or after food. The maximum recommended daily dose is 1200 mg (three capsules). Always use the lowest effective dose for the shortest duration necessary to control symptoms.

Ibudon soft capsules should be swallowed whole with a glass of water, preferably with or after a meal to reduce the risk of gastrointestinal irritation. The capsules should not be chewed, crushed, or opened. The dosage depends on the condition being treated, the severity of symptoms, and the individual patient's characteristics and risk factors.

Adults

For adults, the recommended initial dose of Ibudon is 400 mg (one soft capsule), taken with or after food. This dose may be repeated every 6 to 8 hours as needed, up to a maximum of 1200 mg (three soft capsules) per day. For acute painful conditions, the first dose may be taken on an empty stomach for faster absorption if gastrointestinal tolerability permits, though subsequent doses should ideally be taken with food.

For conditions requiring ongoing anti-inflammatory effect, such as osteoarthritis or rheumatoid arthritis, the dose should be titrated to the lowest effective level. In clinical practice, many patients achieve adequate symptom control with 400-800 mg daily, which represents a lower dose than the maximum permitted. The European Medicines Agency emphasises that the principle of using the lowest effective dose for the shortest duration applies to all NSAID therapy.

Children

Ibudon 400 mg soft capsules are not recommended for children under 12 years of age due to the high fixed dose and the capsule formulation. For paediatric use, ibuprofen is available in more appropriate formulations such as oral suspensions (e.g., 100 mg/5 mL) that allow weight-based dosing. The standard paediatric dose of ibuprofen is 5-10 mg per kilogram of body weight, given every 6 to 8 hours, with a maximum daily dose of 30 mg/kg. Adolescents aged 12 years and older who weigh more than 40 kg may use adult dosing under medical supervision.

Elderly

Elderly patients are at significantly increased risk of serious complications from NSAID use, particularly gastrointestinal bleeding, cardiovascular events, and renal impairment. The National Institute for Health and Care Excellence (NICE) and other international bodies recommend that NSAIDs should be prescribed to elderly patients only when strictly necessary, at the lowest effective dose, and for the shortest duration. Renal function should be assessed before initiating therapy and monitored periodically during treatment. Co-prescription of a proton pump inhibitor for gastroprotection is recommended for elderly patients requiring NSAID therapy.

Missed Dose

If you miss a dose of Ibudon, take it as soon as you remember, provided it is not close to the time for your next dose. If it is nearly time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. Ibudon is typically used for symptomatic relief rather than continuous therapy, so occasional missed doses are generally not clinically significant.

Overdose

Ibuprofen overdose can range from asymptomatic to potentially life-threatening, depending on the amount ingested. Symptoms of overdose may include nausea, vomiting, epigastric pain, drowsiness, dizziness, headache, and tinnitus. In more severe cases, gastrointestinal bleeding, metabolic acidosis, renal failure, and central nervous system depression (including coma) may occur. Convulsions have been reported rarely.

There is no specific antidote for ibuprofen overdose. Management is supportive and symptomatic. Activated charcoal may be considered if the patient presents within one hour of ingestion of a potentially toxic amount (generally considered to be more than 100 mg/kg in children or more than 6 grams in adults). Gastric lavage is rarely indicated. In case of suspected overdose, seek immediate medical attention or contact your local poison control centre.

What Are the Side Effects of Ibudon?

Like all NSAIDs, Ibudon can cause side effects, although not everybody gets them. The most common side effects are gastrointestinal in nature, including nausea, dyspepsia, and abdominal pain. Serious side effects such as gastrointestinal bleeding and cardiovascular events are uncommon but can occur, particularly with long-term use at high doses.

The side effect profile of ibuprofen is well-characterised through decades of clinical use and extensive post-marketing surveillance. Side effects are grouped below by frequency according to the internationally standardised classification used by the European Medicines Agency. It is important to note that the risk of most adverse effects is dose-dependent and duration-dependent, reinforcing the recommendation to use the lowest effective dose for the shortest necessary period.

The gastrointestinal side effects of ibuprofen are the most frequently encountered in clinical practice. A Cochrane systematic review analysing data from multiple randomised controlled trials confirmed that the risk of GI complications increases with dose and duration. The absolute risk of serious GI events (ulcer bleeding, perforation) is estimated at approximately 1-2% per year for chronic NSAID users, though this risk is substantially higher in patients with additional risk factors.

Regarding cardiovascular side effects, the landmark PRECISION trial published in the New England Journal of Medicine (2016) compared the cardiovascular safety of ibuprofen, naproxen, and celecoxib. The trial demonstrated that ibuprofen at moderate doses was not significantly different from celecoxib regarding composite cardiovascular outcomes, though ibuprofen was associated with a higher rate of renal events. The cardiovascular risk is considered dose-dependent, with daily doses of 1200 mg or less generally carrying a lower risk than higher doses.

If you experience any serious side effects, particularly signs of gastrointestinal bleeding (vomiting blood, dark or bloody stools), allergic reactions (difficulty breathing, swelling of face or throat), chest pain, or signs of kidney problems (reduced urine output, swelling), stop taking Ibudon and seek immediate medical attention.

How Should You Store Ibudon?

Store Ibudon at room temperature below 25°C (77°F), in the original packaging to protect from moisture and light. Keep out of reach and sight of children. Do not use after the expiry date printed on the packaging.

Proper storage of Ibudon is essential to maintain the efficacy and safety of the medication throughout its shelf life. Soft capsules are particularly sensitive to environmental conditions because of the gelatin shell, which can soften, harden, or become sticky under inappropriate storage conditions.

Key storage guidelines for Ibudon include:

• Temperature: Store at room temperature, below 25°C (77°F). Do not refrigerate or freeze, as extreme temperatures can damage the soft capsule shell and alter the dissolution properties of the formulation.
• Humidity: Keep in the original packaging to protect from moisture. The gelatin shell is hygroscopic and can absorb moisture from the environment, leading to softening, sticking, or accelerated degradation.
• Light: Protect from direct sunlight and strong artificial light. While ibuprofen itself is relatively photostable, the soft capsule formulation may be affected by prolonged light exposure.
• Children: Store in a safe location out of the reach and sight of children. Accidental ingestion by children can cause serious harm.
• Expiry date: Do not use Ibudon after the expiry date stated on the blister pack or carton. The expiry date refers to the last day of that month.

Do not dispose of medications via household waste or wastewater. Return unused or expired medicines to a pharmacy for safe disposal. This protects the environment and prevents accidental exposure. Many countries have take-back programmes through community pharmacies specifically for this purpose.

What Does Ibudon Contain?

Each Ibudon soft capsule contains 400 mg of ibuprofen as the active ingredient. The capsule shell and liquid fill contain several excipients necessary for the formulation, stability, and appearance of the product.

The complete composition of Ibudon 400 mg soft capsules includes:

Active ingredient:

• Ibuprofen 400 mg per capsule

Typical excipients in soft capsule formulations include:

• Capsule fill: Macrogol (polyethylene glycol) 600 or similar solubilising agent, potassium hydroxide (pH adjuster)
• Capsule shell: Gelatin, sorbitol or glycerol (plasticiser), purified water
• Colourants: May include titanium dioxide (E171), iron oxide (E172), or other approved colourants depending on the manufacturer

Patients with known allergies to any of these excipients should review the full list of ingredients on the product packaging or the patient information leaflet before taking Ibudon. Patients with hereditary fructose intolerance should note that some soft capsule formulations contain sorbitol. The soft capsule shell is derived from animal gelatin, which may be relevant for patients with dietary or religious restrictions concerning animal-derived products.